Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Details for Australian Patent Application No. 2007202288 (hide)

Owner Dana-Farber Cancer Institute, Inc. The General Hospital Corporation

Inventors Meyerson, Matthew; Sordella, Raffaella; Sellers, William R; Janne, Pasi Antero; Bell, Daphne Winifred; Lynch, Thomas J; Paez, Juan Guillermo; Settleman, Jeffrey E; Johnson, Bruce E; Haber, Daniel A

Agent Pizzeys

Pub. Number AU-B-2007202288

Parent 2005228446

Filing date 21 May 2007

Wipo publication date 14 June 2007

Acceptance publication date 9 February 2012

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

7 June 2007 Complete Application Filed

14 June 2007 Application Open to Public Inspection

  Published as AU-B-2007202288

9 February 2012 Application Accepted

  Published as AU-B-2007202288

7 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202289-Biomedical device mold

2007202287-Anchor